Wexford's Medentech makes a global impact
Wexford-based infection control company Medentech has been ranked in the top six of Fortune Magazine's 'Firms Changing the World on a Global Scale'.
The nomination for the company of 100 employees at the Whitemill Industrial Estate on the Clonard Road, was selected by Fortune Magazine through suggestions from readers around the globe.
Fortune Magazine, a multinational business magazine is published and owned by Time Magazine, in New York City. It is internationally recognised due to its annual high profile publication of company rankings worldwide.
Although Medentech has been successfully running for 35 years, this is the first major global recognition of the innovative, ground-breaking work they produce in Wexford for the international market.
This is not least due to their newly-appointed management team two years ago.
The predominantly female-led team have already created a number of global-leading products, including the world's lowest cost system for pressurised water treatment and the fastest-growing disinfectant to kill the hospital acquired mutant germ that kills most patients in the US.
Michael Gately, MD of Medentech, said that over the past two years, the team at Medentech have achieved things of which he really could only have dreamed and the development pipeline for the next two years goes beyond that.
Other major products produced by Medentech are Aquatabs, the world's no 1 water purification tablets. Aquatabs are used for emergency water treatment in disaster situations by all of the world's major aid agencies, NGOs, relief organisations, defence forces and Ministries of Health.
Medentech is owned by Irish management and Hypred France. The company develops and manufactures disinfectant solutions and water purification tablets to improve access to safe, drinking water worldwide as well as reducing surface contamination in clinical, food and farm environments. With distribution agents in over 100 countries they offer world leading, technologies and expertise. Medentech make 1 billion tablets each year to save the most vulnerable lives of under two year olds.